Literature DB >> 16700177

Vascular anomaly causing subclavian steal and cervical myelopathy in a dog: diagnosis and endovascular management.

Diccon R Westworth1, Karen M Vernau, Sean P Cullen, Craig D Long, V Van Halbach, Richard A LeCouteur.   

Abstract

A 3-year-old dog with cervical myelopathy resulting from a vascular anomaly is described. Marked intradural-extramedullary spinal cord compression was observed, in association with multilevel ectatic anastomotic radicular arterial branches connecting the left and right vertebral arteries. A nonpatent proximal segment of the right subclavian artery had resulted in compensatory enlargement of the left vertebral artery. Flow within the right vertebral artery was retrograde and fed into the patent distal segment of the right subclavian artery. Multiple imaging techniques including myelography, computed tomography, magnetic resonance imaging, and selective digital angiography were used to document this anomaly. To reduce spinal cord compression the largest collateral vessel was embolized without complication. Good clinical response was observed within 6 weeks and improved clinical neurologic function was maintained at the time of a 12-month re-evaluation.

Entities:  

Mesh:

Year:  2006        PMID: 16700177     DOI: 10.1111/j.1740-8261.2006.00138.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  2 in total

1.  Computed tomographic and angiographic assessment of spinal extradural arteriovenous fistulas in a dog.

Authors:  Simona Morabito; Edoardo Auriemma; Paolo Zagarella; Edy Mercuriali; Oriol Domenech; Gualtiero Gandini; Teresa Gagliardo; Eric Zini; Swan Specchi
Journal:  Can Vet J       Date:  2017-03       Impact factor: 1.008

2.  Myelopathy secondary to an intramedullary arteriovenous malformation in a mature dog.

Authors:  Maria Ines De Freitas; Daniel Housley; Abby Caine; Emilie Fauchon; Kerstin Baiker; Davide Corbetta; Giunio B Cherubini
Journal:  J Vet Intern Med       Date:  2021-02-01       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.